Immuneering Income Statement (2020-2026) | IMRX

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
18.29M13.61M26.38M26.39M26.40M26.42M26.50M29.26M29.27M29.27M29.65M29.65M31.05M31.05M35.99M35.99M39.67M44.01M64.69M64.70M
Revenue & cost
Revenue (Quarter)
0.48M0.19M0.18M0.09M0.04M455.00
Gross Profit (Quarter)
0.26M-0.02M0.09M0.05M0.02M455.00
Operating items
Amortization - Intangibles (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Research & Development (Quarter)
6.21M7.95M9.06M7.98M9.36M9.87M10.21M9.45M10.05M11.91M11.20M10.65M11.25M14.86M11.47M10.45M10.87M9.25M10.65M14.00M
Selling, General & Administrative (Quarter)
2.60M3.15M3.95M3.70M3.84M4.11M4.46M4.04M3.87M4.38M4.12M4.25M4.01M3.69M4.01M4.30M4.51M4.49M4.68M5.00M
Other Operating Expenses (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Operating Expenses (Quarter)
8.81M11.10M13.02M11.69M13.21M13.99M14.68M13.50M13.93M16.30M15.33M14.91M15.27M18.56M15.48M14.76M15.38M13.75M15.34M19.00M
Operating Income (Quarter)
-8.54M-11.12M-12.93M-11.65M-13.19M-13.99M-14.68M-13.50M-13.93M-16.30M-15.33M-14.91M-15.27M-18.56M-15.48M-14.76M-15.38M-13.75M-15.34M-19.00M
EBIT (Quarter)
-8.54M-11.12M-12.93M-11.65M-13.19M-13.99M-14.68M-13.50M-13.93M-16.30M-15.33M-14.91M-15.27M-18.56M-15.48M-14.76M-15.38M-13.75M-15.34M-19.00M
Non-operating items
Non Operating Investment Income (Quarter)
-0.00M-0.04M-0.12M-0.01M0.04M0.11M
Interest & Investment Income (Quarter)
0.02M0.14M0.13M0.14M0.22M0.52M0.83M1.17M0.86M0.75M0.80M0.83M0.55M0.42M0.44M0.32M0.42M1.86M1.36M1.08M
Other Non Operating Income (Quarter)
-0.01M-0.12M-0.10M-0.02M0.12M0.22M0.24M0.15M0.48M0.46M0.21M0.01M0.13M0.09M0.31M0.51M0.65M
Net income details
EBT (Quarter)
-64.86M-11.00M-18.08M-19.38M-38.85M-13.60M-14.06M-34.34M-25.99M-15.74M-14.71M-20.42M-20.88M-18.33M-15.23M-20.04M-44.50M-12.08M-32.05M-33.13M
Profit After Tax (Quarter)
-8.54M-10.78M-12.90M-0.01M-12.84M37.29M0.03M-12.19M-12.60M38.38M-14.31M-14.08M-14.60M-18.05M-15.05M-14.43M-14.96M-11.50M-13.78M-17.44M
Income from Non-Controlling Interests (Quarter)
-0.12M-0.01M0.04M0.11M0.03M-0.00M0.01M-0.01M-306.000.00M0.01M-0.01M0.08M-0.32M-0.17M
Income from Continuing Operations (Quarter)
-64.86M-11.00M-18.08M-19.38M-38.85M-13.60M-14.06M-34.34M-25.99M-15.74M-14.71M-20.42M-20.88M-18.33M-15.23M-20.04M-44.50M-12.08M-32.05M-33.13M
Consolidated Net Income (Quarter)
-64.86M-11.00M-18.08M-19.38M-38.85M-13.60M-14.06M-34.34M-25.99M-15.74M-14.71M-20.42M-20.88M-18.33M-15.23M-20.04M-44.50M-12.08M-32.05M-33.13M
Income towards Parent Company (Quarter)
-64.86M-11.00M-18.08M-19.38M-38.85M-13.60M-14.06M-34.34M-25.99M-15.74M-14.71M-20.42M-20.88M-18.33M-15.23M-20.04M-44.50M-12.08M-32.05M-33.13M
Net Income towards Common Stockholders (Quarter)
-64.86M-11.00M-18.08M-19.38M-38.85M-13.60M-14.06M-34.34M-25.99M-15.74M-14.71M-20.42M-20.88M-18.33M-15.23M-20.04M-44.50M-12.08M-32.05M-33.13M
Additional items
EPS (Basic) (Quarter)
-3.55-0.81-0.69-0.73-1.47-0.52-0.53-1.20-0.89-0.55-0.50-0.69-0.70-0.61-0.43-0.56-1.12-0.27-0.50-0.51
EPS (Diluted) (Quarter)
-3.55-0.81-0.69-0.73-1.47-0.52-0.53-1.20-0.89-0.55-0.50-0.69-0.70-0.61-0.43-0.56-1.12-0.27-0.50-0.51
Shares Outstanding (Quarter)
18.29M13.61M26.36M26.39M26.39M26.39M26.44M28.65M29.27M28.42M29.37M29.65M29.84M29.98M35.53M35.99M39.67M44.01M64.66M64.70M
Shares Outstanding (Diluted) (Quarter)
18.29M13.61M26.36M26.39M26.39M26.39M26.44M28.65M29.27M28.42M29.37M29.65M29.84M29.98M35.53M35.99M39.67M44.01M64.66M64.70M
EBITDA (Quarter)
-8.54M-11.12M-12.93M-11.65M-13.19M-13.99M-14.68M-13.50M-13.93M-16.30M-15.33M-14.91M-15.27M-18.56M-15.48M-14.76M-15.38M-13.75M-15.34M-19.00M
Interest Expenses (Quarter)
56.34M0.03M5.29M7.88M25.89M0.13M0.22M22.00M12.92M0.19M0.19M6.33M6.15M0.18M0.18M5.60M29.54M0.19M18.08M15.21M